You are here:

Aripiprazole (Abilify®)


Following an abbreviated submission

Aripiprazole tablets 5mg (Abilify) are accepted for restricted use in NHS Scotland for the treatment of schizophrenia. Where aripiprazole is an appropriate antipsychotic, this new dosage is restricted to patients who may benefit from a dose reduction to 5mg daily, taking account of SMC advice issued in August 2004. This 5mg tablet is the same price as the 10mg and 15mg tablets

Drug Details

Drug Name: Aripiprazole (Abilify®)
SMC Drug ID: 187/05
Manufacturer: Bristol-Myers Squibb Pharmaceuticals Ltd
Indication: Schizophrenia
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 11 July 2005